Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS
Content archived on 2024-05-14

Characterization of the role of nuclear factor rip140 in estrogen receptor mediated transcription

Objective



TRANSCRIPTION ACTIVATION BY THE ESTROGEN RECEPTOR AND OTHER NUCLEAR RECEPTORS REQUIRES TRANSCRIPTION INTERMEDIARY FACTORS (TIFS). RECENTLY, A NOVEL NUCLEAR FACTOR (RIP140) HAS BEEN CLONED WHICH BINDS TO THE ESTROGEN RECEPTOR IN THE PRESENCE OF LIGAND. THIS INTERACTION REQUIRES A SHORT SEQUENCE IN THE LIGAND BINDING DOMAIN OF THE ESTROGEN RECEPTOR WHICH IS KNOWN TO BE IMPORTANT FOR ITS TRANSCRIPTIONAL ACTIVITY, AND WHICH IS CONSERVED IN ALL TRANSCRIPTIONALLY ACTIVE NUCLEAR RECEPTORS. THE OBJECTIVE OF THIS PROJECT IS TO ATTEMPT TO ELUCIDATE THE ROLE OF RIP140 IN TRANSCRIPTION, USING TWO APPROACHES. THE EFFECT OF RIP140 ON ESTROGEN RECEPTOR-MEDIATED TRANSCRIPTION WILL BE EXAMINED IN A RECONSTITUTED SYSTEM IN BUDDING YEAST, WHICH IS DEVOID OF ENDOGENOUS NUCLEAR RECEPTORS. THE YEAST TWO HYBRID SYSTEM WILL BE USED TO IDENTIFY ADDITIONAL PROTEINS ASSOCIATED WITH RIP140, AS BIOCHEMICAL EVIDENCE SUGGESTS THAT IT EXISTS AS PART OF A HIGH MOLECULAR WEIGHT COMPLEX WHICH MAY BE IMPORTANT FOR ACTIVATED TRANSCRIPTION.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Call for proposal

Data not available

Funding Scheme

RGI - Research grants (individual fellowships)

Coordinator

Imperial Cancer Research Fund (ICRF)
EU contribution
No data
Address
44,Lincoln's Inn Fields 44
WC2A 3PX London
United Kingdom
Total cost
No data

Participants (1)